country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-16208

Copy Link Print Information

Fluorapacin

Fluorapacin is an anti-tumor agent.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 869811-23-4
Formel: C₁₄H₁₂F₂S₃
Molecular Weight:314.44

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (261 KB)

Fluorapacin Chemical Structure

CAS. Nr.: 869811-23-4

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Fluorapacin is an anti-tumor agent^[1].

Cellular Effect

Cell Line	Type	Value	Description	References
A2780	IC₅₀	0.5 μM Compound: 5	Antitumor activity against human A2780 cell line by RTCES assay Antitumor activity against human A2780 cell line by RTCES assay	[PMID: 16828553]
HeLa	IC₅₀	0.29 μM Compound: 5	Antitumor activity against human HeLa cell line by RTCES assay Antitumor activity against human HeLa cell line by RTCES assay	[PMID: 16828553]
HepG2	IC₅₀	>100 μM Compound: 5	Antitumor activity against human HepG2 cell line by RTCES assay Antitumor activity against human HepG2 cell line by RTCES assay	[PMID: 16828553]
HT-1080	IC₅₀	1 μM Compound: 5	Antitumor activity against human HT1080 cell line by RTCES assay Antitumor activity against human HT1080 cell line by RTCES assay	[PMID: 16828553]
Jurkat	IC₅₀	0.15 μM Compound: 5	Antitumor activity against human jurkat cell line by MTT assay Antitumor activity against human jurkat cell line by MTT assay	[PMID: 16828553]
MCF7	IC₅₀	2.1 μM Compound: 5	Antitumor activity against human MCF7 cell line by RTCES assay Antitumor activity against human MCF7 cell line by RTCES assay	[PMID: 16828553]
MDA-MB-231	IC₅₀	3.1 μM Compound: 5	Antitumor activity against human M231 cell line by RTCES assay Antitumor activity against human M231 cell line by RTCES assay	[PMID: 16828553]
NCI-H460	IC₅₀	2.1 μM Compound: 5	Antitumor activity against human H460 cell line by RTCES assay Antitumor activity against human H460 cell line by RTCES assay	[PMID: 16828553]
OVCAR-4	IC₅₀	0.85 μM Compound: 5	Antitumor activity against human OVACR4 cell line by RTCES assay Antitumor activity against human OVACR4 cell line by RTCES assay	[PMID: 16828553]

Chemical Information

CAS. Nr. 869811-23-4
Molecular Weight 314.44
Formel C₁₄H₁₂F₂S₃
SMILES

FC1=CC=C(CSSSCC2=CC=C(C=C2)F)C=C1
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (261 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Quantitative determination of anti-tumor agent bis(4-fluorobenzyl) trisulfide, fluorapacin and its pharmaceutical preparation by high-performance liquid chromatography

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen